StonvexLoading…
StonvexStonvexStonvexCore line items from ACM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $16.14B | $16.11B | $14.38B | $13.15B |
Operating Income | $1.03B | $827.44M | $324.13M | $646.80M |
Net Income | $561.77M | $402.27M | $55.33M | $310.61M |
EPS (Diluted) | $4.21 | $2.95 | $0.39 | $2.18 |
Total Assets | $12.20B | $12.06B | $11.23B | $11.14B |
Total Liabilities | $9.50B | $9.69B | $8.85B | $8.53B |
Cash & Equivalents | $1.59B | $1.58B | $1.26B | $1.17B |
Free Cash Flow OCF − CapEx | $684.93M | $707.89M | $590.38M | $576.62M |
Shares Outstanding | 131.78M | 132.55M | 136.21M | 138.93M |